BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 2995808)

  • 1. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study.
    Wilson PW; Garrison RJ; Castelli WP
    N Engl J Med; 1985 Oct; 313(17):1038-43. PubMed ID: 2995808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study.
    Stampfer MJ; Colditz GA; Willett WC; Manson JE; Rosner B; Speizer FE; Hennekens CH
    N Engl J Med; 1991 Sep; 325(11):756-62. PubMed ID: 1870648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of estrogen on cardiovascular disease. Prospective studies: The Framingham Study.
    Wilson PW
    Postgrad Med; 1989 Apr; Spec No():51-3; discussion 89-90. PubMed ID: 2542911
    [No Abstract]   [Full Text] [Related]  

  • 4. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.
    Nabulsi AA; Folsom AR; White A; Patsch W; Heiss G; Wu KK; Szklo M
    N Engl J Med; 1993 Apr; 328(15):1069-75. PubMed ID: 8384316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noncontraceptive estrogen use and cardiovascular disease.
    Bush TL; Barrett-Connor E
    Epidemiol Rev; 1985; 7():89-104. PubMed ID: 2996919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of postmenopausal estrogen therapy and coronary heart disease.
    Stampfer MJ; Willett WC; Colditz GA; Rosner B; Speizer FE; Hennekens CH
    N Engl J Med; 1985 Oct; 313(17):1044-9. PubMed ID: 4047106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial infarction and estrogen therapy in post-menopausal women.
    Rosenberg L; Armstrong B; Jick H
    N Engl J Med; 1976 Jun; 294(23):1256-9. PubMed ID: 177869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cigarette smoking and risk of stroke in middle-aged women.
    Colditz GA; Bonita R; Stampfer MJ; Willett WC; Rosner B; Speizer FE; Hennekens CH
    N Engl J Med; 1988 Apr; 318(15):937-41. PubMed ID: 3352685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of estrogens as a risk factor for stroke in postmenopausal women.
    Rosenberg SH; Fausone V; Clark R
    West J Med; 1980 Oct; 133(4):292-6. PubMed ID: 7347044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease.
    Grodstein F; Stampfer MJ; Manson JE; Colditz GA; Willett WC; Rosner B; Speizer FE; Hennekens CH
    N Engl J Med; 1996 Aug; 335(7):453-61. PubMed ID: 8672166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long-term impact of 2-3 years of hormone replacement therapy on cardiovascular mortality and atherosclerosis in healthy women.
    Alexandersen P; Tankó LB; Bagger YZ; Qin G; Christiansen C
    Climacteric; 2006 Apr; 9(2):108-18. PubMed ID: 16698657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women.
    Manson JE; Colditz GA; Stampfer MJ; Willett WC; Krolewski AS; Rosner B; Arky RA; Speizer FE; Hennekens CH
    Arch Intern Med; 1991 Jun; 151(6):1141-7. PubMed ID: 2043016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of cigarette smoking in high-risk patients participating in a clinical trial. A substudy from the Heart Outcomes Prevention Evaluation (HOPE) trial.
    Dagenais GR; Yi Q; Lonn E; Sleight P; Ostergren J; Yusuf S;
    Eur J Cardiovasc Prev Rehabil; 2005 Feb; 12(1):75-81. PubMed ID: 15703510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study.
    Kiel DP; Felson DT; Anderson JJ; Wilson PW; Moskowitz MA
    N Engl J Med; 1987 Nov; 317(19):1169-74. PubMed ID: 3657888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen replacement therapy in the elderly.
    Paganini-Hill A
    Zentralbl Gynakol; 1996; 118(5):255-61. PubMed ID: 8701621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of weight, smoking, and estrogen use on the risk of hip and forearm fractures in postmenopausal women.
    Williams AR; Weiss NS; Ure CL; Ballard J; Daling JR
    Obstet Gynecol; 1982 Dec; 60(6):695-9. PubMed ID: 7145267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noncontraceptive estrogens and mortality: long-term follow-up of women in the Walnut Creek Study.
    Petitti DB; Perlman JA; Sidney S
    Obstet Gynecol; 1987 Sep; 70(3 Pt 1):289-93. PubMed ID: 3627576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone replacement therapy and the risk of stroke. Follow-up of a population-based cohort in Sweden.
    Falkeborn M; Persson I; Terént A; Adami HO; Lithell H; Bergström R
    Arch Intern Med; 1993 May; 153(10):1201-9. PubMed ID: 8388207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoking and hypertension as predictors of cardiovascular risk in population studies.
    Kannel WB; Higgins M
    J Hypertens Suppl; 1990 Sep; 8(5):S3-8. PubMed ID: 2286855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.